Cellectar Biosciences Inc.

CLRB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.31

-$0.04 (-1.70%)

Sep 22, 2026, 11:16 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	13.2M	23.29M	9.56M	19.87M	35.7M	57.17M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	29.78K	29.78K	29.78K	81.21K	81.21K	81.21K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	842.43K	961.67K	888.23K	663.24K	n/a	n/a
Total Current Assets	14.04M	24.25M	10.45M	20.53M	36.57M	57.94M
Property-Plant & Equipment	910.08K	1.19M	1.59M	978.98K	549.14K	638.35K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	939.86K	1.22M	1.62M	1.06M	630.35K	719.56K
Total Assets	14.98M	25.47M	12.08M	21.59M	37.2M	58.66M
Account Payables	1.44M	4.11M	5.62M	2.56M	1.42M	1.43M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.32M	4.59M	17.61M	7.98M	1.94M	n/a
Total Current Liabilities	4.75M	9.39M	25.36M	11.5M	3.99M	3.56M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.38M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	309.4K	1.79M	494K	552.98K	166.29K	301.74K
Total Liabilities	5.06M	11.18M	25.85M	12.05M	4.16M	3.86M
Total Debt	409.59K	494K	552.98K	603.83K	301.74K	421.64K
Book Value	9.92M	14.29M	-13.78M	9.54M	33.05M	54.79M
Book Value Per Share	3.80	11.55	-33.82	40.54	178.57	829.69
Common Stock	42	461	207	94	611	454
Retained Earnings	-269.13M	-247.34M	-202.76M	-159.99M	-150.9M	-126.78M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	9.92M	14.29M	-13.78M	9.54M	33.05M	54.79M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a